A study comparing a new three-drug treatment for HIV/AIDS patients with an older drug regimen in use since the mid-1990s shows the newer combination caused fewer side effects and was easier for patients to tolerate. The study, reported in the New England Journal of Medicine, tenofovir DF, emtricitabine and efavirenz, which currently are available in two pills and may be combined in one pill soon, the researchers said.

Full Story:
HealthDay News

Related Summaries